Fred Kurland

Chief Financial Officer, Corcept Therapeutics.

Companies

Aridis Pharmaceuticals, Inc.Chief financial officer Aug 13, 2018 to Jun 15, 2023¹
XOMA Royalty CorpChief financial officer Mar 2, 2009 to Apr 7, 2015²
XOMA Royalty CorpVP Finance Jan 2, 2009 to Jan 2, 2009³
Corcept TherapeuticsChief financial officer Mar 6, 2006 to Mar 6, 2006⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Aridis Pharmaceuticals, Inc.4,000 shares⁵Jun 5, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 5, 2023Exercised options 4,000 shares of Aridis Pharmaceuticals, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAridis Pharmaceuticals, Inc., Chief financial officer
2
SEC EDGARXOMA Royalty Corp, Chief financial officer
3
SEC EDGARXOMA Royalty Corp, VP Finance
4
SEC EDGARCorcept Therapeutics, Chief financial officer
5
SEC EDGARAridis Pharmaceuticals, Inc. shares after the filing of Jun 5, 2023